Oct 24 |
Moderna Named a Top Employer by Science for Tenth Consecutive Year
|
Oct 24 |
Moderna’s norovirus vaccine enters Phase III trials in the UK
|
Oct 23 |
Moderna, Inc. (NASDAQ:MRNA) Isn’t Seeing Any Love From Mutual Or Hedge Funds
|
Oct 23 |
PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo
|
Oct 23 |
Moderna, Inc. (MRNA): Leading the Way in mRNA Vaccines and Respiratory Health
|
Oct 23 |
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
|
Oct 22 |
We Think Moderna Still Has A Future
|
Oct 22 |
Moderna: Assessing The Impact Of GSK's Patent Lawsuit
|
Oct 21 |
Why Moderna (MRNA) Dipped More Than Broader Market Today
|
Oct 21 |
Moderna Gets Sued by Northwestern University Over Patents Related to COVID Vaccines
|